Related Experiment Videos
"In Safe Hands" - A costly integrated care program with limited benefits in stroke unit care
Sheila Jala1, Sarah Giaccari2, Melissa Passer1
1Neurology Department, Royal North Shore Hospital, St Leonards, NSW 2065, Australia.
Summary
The "In Safe Hands" program, using structured interdisciplinary bedside rounds, did not improve stroke care outcomes or patient satisfaction in an Australian hospital. This costly intervention showed limited benefits in an established stroke unit.
Area of Science:
- Health Services Research
- Clinical Quality Improvement
- Stroke Medicine
Background:
- Accountable care unit models, including structured interdisciplinary bedside rounds (SIBR), show promise in improving healthcare delivery.
- The
- In Safe Hands
- (ISH) program, incorporating SIBR, aims to enhance care coordination.
- Previous studies report reduced length of stay, potential cost savings, and improved satisfaction with SIBR.
Purpose of the Study:
- To assess the impact of implementing the ISH program on a stroke unit in Sydney, Australia.
- The study evaluated effects on length of stay, re-admission rates, adverse events, and patient/nursing satisfaction.
- To determine if ISH benefits are translatable to the Australian healthcare system and established units.
Main Methods:
- Prospective cohort study involving 200 participants.
- Data collected pre- and post-implementation of the ISH program.
- Key outcome measures included length of stay, re-admission rates, adverse events, and patient/nursing satisfaction scores.
Main Results:
- No significant difference was observed in median length of stay (5 vs. 4 days, P=0.55).
- The incidence of adverse events did not significantly change (10% vs. 12%, P=0.82).
- Stroke outcome disability scores, patient, and nursing satisfaction remained unaffected. The ISH program incurred costs of approximately AUD$1805/week.
Conclusions:
- The ISH program, despite its components, yielded limited benefits in a well-established acute stroke unit.
- The intervention proved to be costly with no significant improvements in key clinical or satisfaction outcomes.
- Further discussion is needed regarding potential reasons for the intervention's failure in this specific healthcare setting.